Meeting
2012 Gastrointestinal Cancers Symposium
Evaluation of the prognostic value of guanylyl cyclase C (GCC) lymph node (LN) classification in patients with stage II colon cancer: A pooled analysis.
Authors
Daniel J. Sargent
Mayo Clinic, Rochester, MN
Daniel J. Sargent , Qian Shi , Murray B. Resnick , Stephen Lyle , Michael O. Meyers , Atoussa Goldar-Najafi , Thomas E. Clancy , Sharlene Gill , Jean-Francois Haince , Yves Fradet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 443)
DOI
10.1200/jco.2012.30.4_suppl.443
Abstract #
443
Poster Bd #
B14
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2.
First Author: Joanna Szkandera
Poster
2022 ASCO Annual Meeting
Cellworks Singula therapy response index (TRI) predicts clinical outcomes for esophageal adenocarcinoma: MyCare-004.
First Author: Elizabeth Catherine Smyth
Poster
2020 ASCO Virtual Scientific Program
Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.
First Author: Zhaohui Jin
Poster
2020 Gastrointestinal Cancers Symposium
Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.
First Author: Gunnar Folprecht